CAS: 1014983-00-6; 4-(4-Chloro-5-(2,5-Dimethyl-7-(Pentan-3-yl)Pyrazolo[1,5-A]Pyrimidin-3-yl)Thiazol-2-yl)Morpholine
- 英文名称4-(4-Chloro-5-(2,5-Dimethyl-7-(Pentan-3-yl)Pyrazolo[1,5-A]Pyrimidin-3-yl)Thiazol-2-yl)Morpholine
- 中文名称4-(4-氯-5-(2,5-二甲基-7-(戊-3-基)吡唑并[1,5-A]嘧啶-3-基)噻唑-2-基)吗啉
- IUPAC名称4-(4-chloro-5-(2,5-dimethyl-7-(pentan-3-yl)pyrazolo[1,5-a]pyrimidin-3-yl)thiazol-2-yl)morpholine
- 其它别名Tildacerfont; Pyrazolo[1,5-A]Pyrimidine, 3-[4-Chloro-2-(4-Morpholinyl)-5-Thiazolyl]-7-(1-Ethylpropyl)-2,5-Dimethyl-; 4-(4-Chloro-5-(2,5-Dimethyl-7-(Pentan-3-yl)Pyrazolo[1,5-A]Pyrimidin-3-yl)Thiazol-2-yl)Morpholine; 4-{4-Chloro-5-[2,5-Dimethyl-7-(Pentan-3-yl)Pyrazolo[1,5-A]Pyrimidin-3-Yl]-1,3-Thiazol-2-Yl}Morpholine; Tildacerfont, 10 Mm In Dmso
- CAS编号1014983-00-6
- FDA UNII编号:09QCEV5481
- 分子式:C20H26ClN5OS分子量:419.98
- 产品CID: 28190
- 产品分类Inhibitors/Agonists → GPCR/G Protein → CRF Receptor
MSDS等安全信息
合成工艺路线路线简述
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
主要参考文献
1: Zorrilla EP, Logrip ML, Koob GF. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol. 2014 Apr;35(2):234-44. doi: 10.1016/j.yfrne.2014.01.001. Epub 2014 Jan 20. Review.
合成参考文献
参考文献:10.1007/978-981-97-1639-5_30
摘要:Joshi R. Congenital Adrenal Hyperplasia. 2024. In: Children with Differences in Sex Development.
参考文献:10.1007/978-3-031-66296-6_11
摘要:Witchel SF, Oberfield SE, Fisher AS, Trapp C. Congenital Adrenal Hyperplasia. 2024. In: Pediatric Endocrinology.
参考文献:10.1007/978-3-031-66296-6_10
摘要:Bethin KE, Majumdar I, Muglia LJ. Adrenal Insufficiency. 2024. In: Pediatric Endocrinology.
📝 需求与反馈
尽可能描述清楚需求与问题信息
